Vygon Group Expands Into Singapore

Vygon Group is expanding its operations, opening a subsidiary in Singapore.
 
The move is designed to strengthen the company’s presence in the Asia-Pacific region, a strategic market for the group. The new site will be a base for local development and direct sales in the area.
 
“We are delighted with the opening of our subsidiary in Singapore, at the crossroads of the strategic markets of Asia and Oceania,” said Stéphane Regnault, chairman of Vygon’s board of management. “This subsidiary brings us closer to our customers, nearly all of whom will be within a six-hour reach. Our goal is to provide highly tailored solutions for specific market needs.”
 
Thanapathy Kumaraiah, regional director for Asia-Oceania, will manage the subsidiary, whose role is to provide the necessary support to Vygon’s distribution network in the region: product registration, marketing support and training seminar organization. Four countries will be managed as priority targets: Australia, China, Indonesia and South Korea.
 
“The Asia-Pacific region faces numerous challenges, with countries that do not follow the CE mark and have specific and significant demands in terms of documentation and clinical trials,” said Christophe Deffontaines, vice president, Asia-Pacific. “We aim to increase our sales in the region six-fold, by providing customized marketing and training to our distributors in the local environment.”
 
Vygon has divided its markets into six geographical areas. Among these, the Asia-Pacific area includes Asia and Oceania, along with the Middle East and South Africa. Heavily populated China, India and Indonesia are included within the Asia-Pacific region. Vygon already has a presence in a number of countries in this territory through its network of 25 offices and subsidiaries. The most recent offices opened were in Japan (2009), Dubai (2004) and India (1995).
 
Vygon Group executives expect to double its sales by 2022, with a target of 20 percent of Group sales coming from Asia-Pacific by that point.
 
Vygon designs, manufactures and markets high-tech single-use medical devices for health care professionals in hospital and for private and independent practitioners, offering products in a number of clinical specialties including neonatology, adult and pediatric critical care, anesthesia, oncology, emergency, surgery and home care. The company distributes more than 200 million products annually in more than 100 countries through its network of 25 subsidiaries and 79 distributors.

A family company founded in 1962, Vygon is based in Ecouen, in France’s greater Paris region. It employs 1,800 staff worldwide.